multi target TKI
Results Trial description recap V1

Apitolisib - Axitinib - Cabozantinib - Dovitinib - Pazopanib - Sorafenib - Sunitinib - Tivozanib


Advanced breast cancer (metastatic)

all type of patients 6 trials

HR+ HER2- 0 trials

Renal-cell carcinoma (advanced)

all type of patients 16 trials

- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons